Meridian Bioscience Inc.

Meridian Bioscience Inc.

Herstellung medizinischer Geräte

Cincinnati, OH 21,679 followers

Über uns

Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits, rare reagents, specialty biologicals and components. Utilizing a variety of methods, our diagnostic tests provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as infections and lead poisoning. Meridian’s diagnostic products are used outside of the human body and require little or no special equipment. The Company’s diagnostic products are designed to enhance patient well-being while reducing the total outcome costs of health care. Meridian has strong market positions in the areas of gastrointestinal and upper respiratory infections, and blood lead level testing. In addition, Meridian is a supplier of rare reagents, specialty biologicals and components used by organizations in the life science and agri-bio industries engaged in research. Many companies also utilize Meridian’s products as components in the manufacture of diagnostics. The Company markets its products and technologies to hospitals, reference laboratories, research centers, diagnostics manufacturers, and agri-bio companies in more than 70 countries around the world. Meridian’s website address is www.meridianbioscience.com.

Website
http://www.meridianbioscience.com
Industrie
Herstellung medizinischer Geräte
Größe des Unternehmens
501-1,000 employees
Hauptsitz
Cincinnati, OH
Typ
In Privatbesitz
Spezialitäten
integrated life science, diagnostic testing, purified reagents, assay reagents, antigens, antibodies, contract biological R&D, bioscience research, diagnostic, infectious disease, immunoassay diagnostics, molecular diagnostics, and EIA testing

Produkte

Standorte

Employees at Meridian Bioscience Inc.

Aktualisierungen

Verbundene Seiten

Ähnliche Seiten

Jobs durchsuchen

Finanzierung

Meridian Bioscience Inc. 3 total rounds

Letzte Runde

Grant

US$ 2.5M

Siehe mehr Informationen auf crunchbase